1
/
of
0
FDA Drug Approval, N205874, AURYXIA
FDA Drug Approval, N205874, AURYXIA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 205874
Company: KERYX BIOPHARMS
Drug Name: AURYXIA
Active Ingredients: FERRIC CITRATE
Strength: EQ 210MG IRON
Dosage Form/Route: TABLET;ORAL
Action Date: 09/05/2014
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: KERYX BIOPHARMS
Drug Name: AURYXIA
Active Ingredients: FERRIC CITRATE
Strength: EQ 210MG IRON
Dosage Form/Route: TABLET;ORAL
Action Date: 09/05/2014
Marketing Status: Prescription
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details